Projects per year
Personal profile
Experience
- 2023.08- Associate Dean, College of Management, Taipei Medical University
- 2023.08- Director, School of Health Care Administration, Taipei Medical University
- 2020 Professor, School of Health Care Administration, Taipei Medical University
- 2016 Associate Professor,School of Health Care Administration, Taipei Medical University
Fingerprint
Dive into the research topics where Wei Pin Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
114年度「食品雲資料轉譯與品質評估」
Chang, W. P. (PI)
1/1/25 → 12/31/25
Project: A - Government Institution › c - Ministry of Health and Welfare
-
113年度「食品雲資料轉譯與品質評估」
Chang, W. P. (PI)
1/1/24 → 12/31/24
Project: A - Government Institution › c - Ministry of Health and Welfare
-
「異」起雲健康-建構APP紀錄異位性皮膚炎
Chang, W. P. (PI)
7/1/23 → 2/29/24
Project: A - Government Institution › b - National Science and Technology Council
-
112年度「食品雲資料轉譯與品質評估」
Chang, W. P. (PI)
1/1/23 → 12/31/23
Project: A - Government Institution › c - Ministry of Health and Welfare
-
Utilize the Recommendation System for Food Fraud Event and Build Mobile Consumer Application
Chang, W. P. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
Identifying breast cancer risk factors and evaluating biennial mammography screening efficacy using big data analysis in Taiwan
Huang, C. C., Lu, T. P., Wang, Y. J., Chen, B. F., Yang, H. T., Chang, W. P. & Tseng, L. M., Dec 2025, In: Scientific Reports. 15, 1, 16250.Research output: Contribution to journal › Article › peer-review
-
Cost-effectiveness analysis of pembrolizumab with chemotherapy for metastatic nonsquamous non-small cell lung cancer in Taiwan
Lee, W.-L., Chou, W.-H., Chang, W.-P., Chang, T.-W., Kuo, C.-N. & Chang, W.-C., Dec 15 2024, In: Journal of Food and Drug Analysis. 32, 4, p. 568-576 9 p., 14.Research output: Contribution to journal › Article › peer-review
-
Trends in the incidence of head and neck cancer: A nationwide population-based study
Yang, T. H., Xirasagar, S., Cheng, Y. F., Chen, C. S., Chang, W. P. & Lin, H. C., May 2023, In: Oral Oncology. 140, 106391.Research output: Contribution to journal › Article › peer-review
12 Citations (Scopus) -
Chronic obstructive pulmonary disease is associated with a higher risk of functional gastrointestinal disorders
Chiu, Y. C., Chang, W. P., Tang, G. J., Lan, T. Y., Lee, K. Y. & Su, V. Y. F., Jun 2022, In: Respiratory Medicine. 197, 106833.Research output: Contribution to journal › Article › peer-review
7 Citations (Scopus) -
Corrigendum to “Chronic obstructive pulmonary disease is associated with a higher risk of functional gastrointestinal disorders” [Respir. Med. 197 (2022) 106833] (Respiratory Medicine (2022) 197, (S0954611122000981), (10.1016/j.rmed.2022.106833))
Chiu, Y. C., Chang, W. P., Tang, G. J., Lan, T. Y., Lee, K. Y. & Su, V. Y. F., Aug 1 2022, In: Respiratory Medicine. 200, 106893.Research output: Contribution to journal › Comment/debate › peer-review
Open Access
Datasets
-
Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis
Chang, Y.-H. (Creator), Li, W.-H. (Contributor), Chang, Y. (Creator), Peng, C.-W. (Creator), Cheng, C.-H. (Contributor), Chang, W.-P. (Creator) & Chuang, C.-M. (Contributor), Figshare, 2016
DOI: 10.6084/m9.figshare.c.3642380.v1, https://figshare.com/collections/Front-line_intraperitoneal_versus_intravenous_chemotherapy_in_stage_III-IV_epithelial_ovarian_tubal_and_peritoneal_cancer_with_minimal_residual_disease_a_competing_risk_analysis/3642380/1
Dataset
-
Additional file 1: of Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis
Chang, Y.-H. (Creator), Li, W.-H. (Contributor), Chang, Y. (Creator), Peng, C.-W. (Creator), Cheng, C.-H. (Contributor), Chang, W.-P. (Creator) & Chuang, C.-M. (Contributor), Figshare, 2016
DOI: 10.6084/m9.figshare.c.3642380_d1.v1, https://springernature.figshare.com/articles/dataset/Additional_file_1_of_Front-line_intraperitoneal_versus_intravenous_chemotherapy_in_stage_III-IV_epithelial_ovarian_tubal_and_peritoneal_cancer_with_minimal_residual_disease_a_competing_risk_analysis/4462352/1
Dataset